Human Genome Epidemiology Literature Finder
Records 1 - 13 (of 13 Records) |
Query Trace: Adenocarcinoma and CD74[original query] |
---|
The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Sep 24 (9): 2364-70. Kim H R, Lim S M, Kim H J, Hwang S K, Park J K, Shin E, Bae M K, Ou S-H I, Wang J, Jewell S S, Kang D R, Soo R A, Haack H, Kim J H, Shim H S, Cho B |
[Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation]. Zhonghua bing li xue za zhi Chinese journal of pathology 2015 Sep 44 (9): 639-43. Zhong Shan, Zhang Haiping, Bai Dongyu, Gao Dehong, Zheng Jie, Ding |
Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients. Oncotarget 2015 Oct . Wang Rui, Zhang Yang, Pan Yunjian, Li Yuan, Hu Haichuan, Cai Deng, Li Hang, Ye Ting, Luo Xiaoyang, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu |
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 1 21 (16): 3631-9. Drilon Alexander, Wang Lu, Arcila Maria E, Balasubramanian Sohail, Greenbowe Joel R, Ross Jeffrey S, Stephens Phil, Lipson Doron, Miller Vincent A, Kris Mark G, Ladanyi Marc, Rizvi Naiyer |
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative. Oncotarget 2016 Mar . Lim Sun Min, Kim Eun Young, Kim Hye Ryun, Ali Siraj M, Greenbowe Joel R, Shim Hyo Sup, Chang Hyun, Lim Seungtaek, Paik Soonmyung, Cho Byoung Ch |
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression. Oncotarget 2018 Feb 9 (11): 9661-9671. Trombetta Domenico, Graziano Paolo, Scarpa Aldo, Sparaneo Angelo, Rossi Giulio, Rossi Antonio, Di Maio Massimo, Antonello Davide, Mafficini Andrea, Fabrizio Federico Pio, Manzorra Maria Carmina, Balsamo Teresa, Centra Flavia, Simbolo Michele, Pantalone Angela, Notarangelo Michela, Parente Paola, Lucia Dimitri Maria Cecilia, Bonfitto Antonio, Fiordelisi Fabiola, Storlazzi Clelia Tiziana, L'Abbate Alberto, Taurchini Marco, Maiello Evaristo, Fazio Vito Michele, Muscarella Lucia An |
Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 8 14 (11): 2003-2008. Pan Yunjian, Zhang Yang, Ye Ting, Zhao Yue, Gao Zhendong, Yuan Hui, Zheng Difan, Zheng Shanbo, Li Hang, Li Yuan, Jin Yan, Sun Yihua, Chen Haiqu |
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients. Oncology letters 2020 4 19 (5): 3495-3505. Ruan Xingya, Sun Yonghua, Wang Wei, Ye Jianwei, Zhang Daoyun, Gong Ziying, Yang Mingx |
Identification of Novel CD74-NRG2? Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2020 2 15 (6): 948-961. Kohsaka Shinji, Hayashi Takuo, Nagano Masaaki, Ueno Toshihide, Kojima Shinya, Kawazu Masahito, Shiraishi Yuichi, Kishikawa Satsuki, Suehara Yoshiyuki, Takahashi Fumiyuki, Takahashi Kazuhisa, Suzuki Kenji, Takamochi Kazuya, Mano Hiroyu |
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung. Journal of cancer research and clinical oncology 2021 Apr . Ueda Daisuke, Ito Masaoki, Tsutani Yasuhiro, Giménez-Capitán Ana, Román-Lladó Ruth, Pérez-Rosado Ana, Aguado Cristina, Kushitani Kei, Miyata Yoshihiro, Arihiro Koji, Molina-Vila Miguel Angel, Rosell Rafael, Takeshima Yukio, Okada Morihi |
A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy. Thoracic cancer 2022 9 13 (21): 3063-3067. Chen Kai, Li Wen, Xi Xiaoming, Zhong J |
Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma. Cancer genomics & proteomics 2023 7 20 (4): 404-411. Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova, Katerina Houfkova, Mahyar Sharif Bagheri, Tereza Knizkova, Bohuslava Vankova, Jindra Windrichova, Petr Macan, Vaclav Babuska, Martin Pes |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: